BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11070562)

  • 1. Hormone replacement therapy and ischaemic heart disease: continuing questions but still no answers.
    Lloyd G
    Int J Clin Pract; 2000 Sep; 54(7):416-7. PubMed ID: 11070562
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
    Rexrode KM; Manson JE
    Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929
    [No Abstract]   [Full Text] [Related]  

  • 8. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy and ischemic heart disease--a dangerous cocktail? Changes in the collected evidence].
    Lassen PD; Stender S
    Ugeskr Laeger; 2003 Oct; 165(41):3909-13. PubMed ID: 14579550
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy - where to from here? (with response from Sandra Coney).
    Fenton A
    N Z Med J; 2002 Sep; 115(1161):U163; discussion U163. PubMed ID: 12386670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials].
    Arnesen H; Qvigstad E
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4064. PubMed ID: 9441436
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effectiveness of estrogen replacement therapy to reduce ischemic heart disease--revaluation].
    Ben-Chetrit A; Zacut D; Shimonovitz S
    Harefuah; 2003 Jan; 142(1):32-7, 78. PubMed ID: 12647487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: "Reproductive hormone exposure timing and ischemic heart disease: complicated answers to a simple question" by Merz et al. [Maturitas 65 (2010) 297-298].
    Dören M; Greiser EM
    Maturitas; 2010 Jul; 66(3):329; author reply 329-30. PubMed ID: 20418031
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone therapy is no heart helper. The latest chapter in the sage of hormone replacement therapy warns that it may harm, not help, the heart.
    Harv Heart Lett; 2002 Oct; 13(2):2-3. PubMed ID: 12393342
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risk of venous thromboembolism during postmenopausal hormone therapy].
    Pedersen AT; Ottesen B
    Ugeskr Laeger; 1996 Nov; 158(48):6923-4. PubMed ID: 8984757
    [No Abstract]   [Full Text] [Related]  

  • 17. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
    von Schoultz B
    Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone replacement therapy: the right choice for your patient?
    Leong SL; Erickson DR; Pees RC
    J Fam Pract; 2005 May; 54(5):428-36. PubMed ID: 15865901
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone therapy: continuing discussion and debate.
    Apgar BS; Weismiller DG
    Am Fam Physician; 2003 Apr; 67(7):1444, 1446, 1449. PubMed ID: 12722847
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone replacement therapy and risk of ischemic heart disease and other causes of death. A review of studies published 1970-1992].
    Eiken PA
    Ugeskr Laeger; 1993 Dec; 155(50):4067-76. PubMed ID: 8273224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.